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a  b  s  t  r  a  c  t
Baeyer–Villiger  monooxygenases  are  attractive  “green”  catalysts  able  to produce  chiral  esters  or  lactones
starting  from  ketones.  They  can act  as natural  equivalents  of peroxyacids  that  are  the  catalysts  classically
used  in  the  organic  synthesis  reactions,  consisting  in  the cleavage  of C C  bonds  with  the  concomitant
insertion  of  an  oxygen  atom.
In this  study,  two type  I  BVMOs  have  been  identiﬁed  for the  ﬁrst  time  in  photosynthetic  eukaryotic
organisms,  the  red alga  Cyanidioschyzon  merolae  (Cm)  and  the  moss  Physcomitrella  patens  (Pp).  A  biocat-
alytic  characterization  of these  newly  discovered  enzymes,  expressed  in recombinant  forms,  was  carried
out. Both  enzymes  could  be puriﬁed  as  holo  enzymes  containing  a FAD  cofactor.  Their  thermostability
was  investigated  and  revealed  that  the  Cm-BVMO  is  the  most  thermostable  type  I BVMO  with  an  appar-
ent  melting  temperature  of  56 ◦C.  Substrate  proﬁling  revealed  that  both  eukaryotic  BVMOs  accept  a wide
range  of ketones  which include  aromatic,  aliphatic,  aryl  aliphatic  and  bicyclic  ketones.  In particular,  linear
aliphatic  ketones  (C9  and  C12),  carrying  the  keto  functionality  in  different  positions,  resulted  to  be  the
best  substrates  in  steady  state kinetic  analyses.  In order  to restore  the  BVMO-typifying  sequence  motif  in
the  Pp-BVMO,  a mutant  was  prepared  (Y160H).  Intriguingly,  this  mutation  resulted  in higher  activities
on  most  tested  substrates.  The  recombinant  enzymes  displayed  kcat values  in the  0.1–0.2  s−1 range,  which
is  relatively  low  when  compared  with  other  known  type  I  BVMOs.  This  may  hint to a  role  in secondary
tosynmetabolism  in  these  pho
. Introduction
The Baeyer–Villiger reaction is an important oxidative reaction
n organic synthesis ﬁrstly reported by Adolf von Baeyer and
ictor Villiger in 1899 [1]. In this reaction, ketones are oxidized
nto the corresponding esters or lactones by peroxyacids resulting
n oxygen insertion next to the carbonyl group. Reagents able
o carry out the Baeyer–Villiger reaction are peroxyacids such
s meta-chloroperoxybenzoic acid, triﬂuoroperoxyacetic acid,
eroxyacetic acid, hydrogen peroxide and others. Such molecules
re expensive, toxic and hazardous; they are strong oxidants and
eact with other functional groups [2]. The reaction mechanism
onsists in the nucleoﬁlic attack of peroxyacid to the carbonyl
unction of the substrate forming a tetrahedral intermediate called
he “Criegee intermediate”, which undergoes rearrangement to
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ttp://dx.doi.org/10.1016/j.molcatb.2013.10.006thetic  organisms,  though  their  exact function  remains  to  be  established.
© 2013 Elsevier B.V. All rights reserved.
the corresponding ester or lactone; one of the group attached to
the carbonyl carbon migrates onto the electron deﬁcient oxygen
atom with the simultaneous dissociation of the O O bond. The
regiochemistry of the reaction depends on the relative migratory
ability of the substituents attached to the carbonyl group and on
the stereoelectronic features of the substrate [3]. Moreover, if the
migrating carbon is chiral the stereochemistry is retained [4].
Baeyer–Villiger monooxygenases (BVMOs) are ﬂavin-
containing monooxygenases able to catalyze a remarkable wide
variety of oxidative reactions [5], which are difﬁcult to obtain
chemically: the nucleophilic oxidation of carbonyl groups but also
the electrophilic oxidation of heteroatoms such as sulphur [6,7],
nitrogen [8] and boron [9], with good enantioselectivity. Complete
enantioselectivity has been reported for the epoxidation of few
selected oleﬁn substrates too [10]. Indeed, the great potential of
these enzymes is the ability to produce chiral lactones and sulfox-
ides by asymmetric synthesis and this makes them attractive for
application in industrial organic synthesis [11,12].
BVMOs contain a ﬂavin cofactor, FAD or FMN, not covalently
but tightly bound to the enzyme. This ﬂavin cofactor has to be acti-
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quivalents allowing molecular oxygen binding. Depending on
ofactor usage, BVMOs can be classiﬁed into two  types [13].
ype I BVMOs are FAD and NADPH dependent and contain two-
inucleotide binding domains (-folds) known as Rossman
otifs, one for the FAD binding and the other one for the NADPH
inding. They are composed of only one polypeptide. Type II BVMOs
re FMN  and NADH dependent and consist of two distinct subunits,
 dehydrogenase using NADH to reduce FMN  and a second sub-
nit able to perform the Baeyer–Villiger reaction using the reduced
avin.
There is another monooxygenase, MtmOIV, able to perform
he Baeyer–Villiger reaction, involved in mithramycin biosynthe-
is. Mithramycin is a polyketide anticancer antibiotic produced
y the soil bacterium Streptomyces argillaceus (ATCC 12956) and
ther streptomycetes [14]. Sequence analysis and crystal structure
evealed that MtmVIO can not be classiﬁed as a type I or type II
VMOs but it appears to be an atypical BVMO belonging to a differ-
nt ﬂavoprotein monooxygenase family [15].
The best-characterized BVMOs are those of type I, which display
ood substrate promiscuity and are therefore attractive for syn-
hetic applications [16]. In particular, the most famous enzymes are
yclohexanone monooxygenase (CHMO) from Acinetobacter NCIMB
871 and phenylacetone monooxygenase (PAMO) from Thermobi-
da fusca. The former enzyme was also the ﬁrst one to be described,
n the middle seventies [17]. Up to ten years ago, however, few
VMOs had been cloned and overexpressed. Thanks to the vast
enetic information that has become available by genome sequenc-
ng, the number of recombinant BVMOs has increased considerably.
n particular, the technique of genome mining has proved to be
n efﬁcient approach to discover new biocatalysts. Previous stud-
es performed by this approach showed that type I BVMOs were
resent in a vast variety of bacteria and fungi, but no representative
as found in Archea, plants or human genomes [18].
In order to ﬁnd novel and promising biocatalysts, we  used
he genome mining approach to uncover BVMOs within speciﬁc
nd unusual organisms. Using the sequence of a prototype BVMO,
henylacetone monooxygenase (PAMO), as template and the “ﬁn-
erprint” motif for type I BVMOs (FxGxxxHxxxWP/D; [19]) as
iscriminant, we have identiﬁed two new putative BVMO-encoding
enes in the red alga Cyanidioschyzon merolae (Cm) and in the moss
hyscomitrella patens (Pp). Photosynthetic eukaryotes appear as
ery uncommon sources for BVMOs. In fact, only two BVMOs from
ukaryotic origin have been cloned and expressed to date. Both
VMOs were derived from fungi: the ascomycetes Cylindrocarpon
adicicola ATCC 11011 [20] and Aspergillus fumigatus Af293 [21]. The
iscovery of BVMOs in photosynthetic eukaryotes is novel and may
rovide new biocatalytic features.
. Experimental
.1. Organisms and culture conditions
Cyanidioschyzon merolae strain 10D (NIES-1332) was  obtained
rom the Microbial Culture Collection of the National Institute
or Environmental Studies, Tsukuba, Japan. Cultures of C. merolae
ere grown at 30 ◦C in M-Allen medium (http://mcc.nies.go.jp), in
00 ml  ﬂasks on a rotatory platform shaker at 70 rpm. Light condi-
ions used were 25–27 mol  photons m−2 sec−1.
E. coli strains (XL1-blue and BL21 (DE3)) were routinely cul-
ured in LB media and supplemented with the antibiotic kanamycin
50 g/ml).The starting culture of Physcomitrella patens was kindly pro-
ided by Dr. Tomas Morosinotto (Department of Biology, University
f Padova). It was cultivated by micro propagation in PpNH4 rich
edium: 0.8 g/l CaNO3 4H2O, 0.25 g/l MgSO4 7H2O, 0.0125 g/llysis B: Enzymatic 98 (2013) 145– 154
FeSO4 7H2O, 500 mg/l NH4 tartrate, 5 g/l glucose, 1 ml  KH2PO4/KOH
buffer pH 7, and 1 ml  trace solution elements per liter. KH2PO4/KOH
buffer contained 25 g KH2PO4 per 100 ml  of milliQ water; pH 7 was
obtained by titrating with 4 M KOH. Trace element solution con-
tained 55 mg/l CuSO4 5H2O, 55 mg/l ZnSO4·7H2O, 614 mg/l H3BO3,
389 mg/l MnCl2·4H2O, 55 mg/l CoCl2·6H2O, 28 mg/l KI, 25 mg/l
Na2MoO4·2H2O. Cultures were grown in a growth chambers at
24 ◦C, with 16 h light/8 h dark photoperiod and a light intensity of
40–50 E. Nutrition media were autoclaved for 20 min  at 121 ◦C
and plant agar (7 g/l) was  added in order to prepare solid media.
2.2. Reagents and enzymes
All chemicals were purchased from Fluka and Sigma–Aldrich
(Milan, Italy). Restriction enzymes were obtained from New
England Biolabs (NEB) or from Promega; PhusionTM High-ﬁdelity
DNA polymerase from Finnzymes; TSAP (Thermosensitive Alkaline
Phosphatase) from Promega; T4 DNA Ligase from NEB. IMAC-Select
Afﬁnity Gel resin was purchased from Sigma–Aldrich.
2.3. Sequence analysis and cloning
The NCBI resource was  used for DNA sequence analysis; searches
and multiple alignments of BVMO sequences were respectively
produced by programs BLAST and ClustalW.
Expression vectors were produced by digestion of pET-28a(+)
with NcoI/NotI and ligation of the ampliﬁed Cm-BVMO and Pp-
BVMO sequences, cut by the same enzymes. These sequences
were obtained by two subsequent PCR reactions, the ﬁrst one
producing a preliminary “large” amplimer, which was then
used for the second ampliﬁcation, by nested mutagenic primers.
The following synthetic oligonucleotides were used for PCR
ampliﬁcation of the target gene from C. merolae genomic DNA:
external primer pair, forward 5′-AGTGATGCGCGTGGCCGGCA-3′
and reverse 5′-AGGTGTCTGCACCTCGCCAGCG-3′; nested primer
pair, forward 5′-TTTGACCGGCCATGGGAGCGGAGCTCAAC-3′
and reverse 5′-GCATCCACCGCGCCGGCGTACAGCGAAG-3′. The
following synthetic oligonucleotides were used for PCR ampliﬁ-
cation of the target gene from P. patens genomic DNA: external
primer pair, forward 5′-ACAGGCCACGGGGGTAGTTCTGTTG-
3′ and reverse 5′-CAACCCTGGACAGCATCGGAAGCCT-3′;
nested primer pair, forward 5′-AAGTATGTCCAATTCCATGGC-
TGAGTTCGATGCTGTTATAGTCGGAG-3′ and reverse 5′-AAACAAT-
GCCCGCGGCCGCCAGCTTGAATCCC-3′. The sequence variant
Y160H was constructed using the QuikChange® II Site-Directed
Mutagenesis Kit of Stratagene using plasmid pET28 Pp-BVMO
as template with the oligonucleotide 5′-GGCTCATCGTACCA-
CACGGGC-3′ and its complementary one.
2.4. Expression, analysis and puriﬁcation of recombinant proteins
The recombinant enzymes, hereafter called Cm-BVMO, Pp-
BVMO and Pp-Y160H-BVMO, were expressed in E. coli BL21 (DE3)
or E. coli ARCTIC Express® (Stratagene). Pre-cultures were carried
out in 5 ml  LB medium at 37 ◦C containing 50 g/ml kanamycin.
Larger cultures were carried out in 1 L LB medium with riboﬂavin
addition (100 M).  The cells were grown in a shaking incubator
at 37 ◦C to an optical density at 600 nm (OD600) of 0.4–0.6, then
induced by addition of IPTG to a ﬁnal concentration of 0.2 mM and
cultivated at 18 ◦C overnight. The cells were harvested by centrifu-
gation (4 ◦C, 10 min, 4500 × g) and washed with Tris/HCl buffer (Tris
50 mM,  pH 8.0). Cell disruption was obtained by French Press and
crude extract was centrifuged (4 ◦C, 20 min, 15,000 × g) to separate
soluble e insoluble fractions. FAD cofactor (at 100 M ﬁnal concen-
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Expression of recombinant protein was checked by SDS-PAGE
nalysis. The identity of the proteins was veriﬁed by immunoblot-
ing using anti His-tag antibodies. Overexpressed proteins were
uriﬁed by immobilized-metal afﬁnity chromatography (IMAC).
oluble fractions obtained from 1 l culture were incubated with the
esin for 1 h at 4 ◦C and then loaded on a 5 ml  column (Bio-Rad).
he column was washed by gravitational ﬂow with three column
olumes of 50 mM Tris/HCl, 300 mM NaCl buffer, then with two
olumn volumes of the same buffer with added 5 mM imidazole.
lution was performed by ﬁve column volumes of 50 mM Tris/HCl,
00 mM imidazole solution. Enzyme concentration was  measured
y spectrophotometry, measuring concentration of free ﬂavin in a
olution of denatured protein and calculated as previously reported
22].
.5. Activity assay, kinetics and ThermoFAD measurements
BVMO activity is usually determined spectrophotometri-
ally by monitoring the consumption of NADPH at 340 nm
ε = 6.22 mM−1 cm−1). Reaction mixtures (1 ml)  contained 50 mM
ris–HCl buffer pH 8.0, 100 M NADPH, 0.4 M pure enzyme, and
0 l of 1 mM of rac-bicyclo[3.2.0]hept-2-en-6-one in dioxane.
dding the enzyme to the mixture started the reaction. One unit
f BVMO is deﬁned as the amount of protein that oxidizes 1 mol
ADPH per minute.
Steady-state kinetic parameters of the different substrates
ere determined using puriﬁed enzymes and substrate concen-
rations ranging from 0 to 5 mM.  Data were ﬁtted using the
ichaelis–Menten equation by the program SigmaPlot.
The apparent unfolding temperatures of the recombinant
nzymes, Tms, were determined using the ThermoFAD method
23]. 30 l of 1 mg/mL  protein in Tris-HCl buffer (50 mM,  pH 7.5)
ere loaded in a Real Time PCR machine (Eppendorf) ﬁtted with
 470–543 nm excitation ﬁlter and a SYBR Green emission ﬁlter
523–543 nm). A temperature gradient from 20 to 90 ◦C was  applied
1 ◦C/min), and ﬂuorescence data were recorded. A sigmoidal curve
as obtained after plotting the ﬂuorescence amount against the
emperature. The Tm values were determined as the maximum of
he derivative of the obtained sigmoidal curve
.6. Substrate screening
The phosphate activity assay was performed according to the
rotocol reported by Riebel [24]. All substrates were dissolved in
ioxane (maximum 5%) and tested in 96 wells plates.
.7. Conversions and GC/GC–MS analysis
For GC and GC–MS analysis, samples of 500 l 50 mM Tris–HCl
pH 7.5) containing 2 mM substrate, 5% dioxane, 100 M NADPH,
.0 M PTDH, 10 mM phosphite and 1 M BVMO were incubated
haking at 25 ◦C from 1 to 20 h. The reactions were stopped by
xtraction with ethyl acetate (3 × 0.5 ml,  including 0.1% mesity-
ene as an internal standard), dried with magnesium sulfate and
nalyzed directly by GC or GC–MS [5] to determine the degree of
onversion.
. Results
.1. Two  new BVMOs from photosynthetic eukaryote organisms
By using the protein sequence of PAMO as template for a
BLASTn search and the consensus motif FxGxxxHxxxWP [19] as
iscriminant (allowing just single conservative mutation), two new
utative type I BVMO enzymes were identiﬁed from two  pho-
osynthetic eukaryotes: Cyanidioschyzon merolae (a red alga) andlysis B: Enzymatic 98 (2013) 145– 154 147
Physcomitrella patens (a moss). Both identiﬁed BVMO sequences
also contained other conserved regions, such as two Rossmann
fold motifs (GXGXX(G/A)) that are known to be involved in dinu-
cleotide cofactor binding [25] and the recently annotated motif
[A/G]GxWxxxx[F/Y]P[G/M]xxxD, which includes residues of the
active site and therefore represents a BVMO-typifying consensus
sequence [24]. A ClustalW alignment of the two proteins with
PAMO and cyclohexanone monooxygenase (CHMO) from Acineto-
bacter NCIMB 9871 is shown in Fig. 1.
With the aim of considering the evolutionary relationships of
the two proteins with other known BVMOs, we selected a set of
24 prototype enzymes among those that are well characterized
as recombinant products and representative for substrate speci-
ﬁcities. We  aligned thus 26 protein sequences and produced the
branching diagram shown in Fig. 2. It resulted that the sequence
from C. merolae most likely shares a common ancestor with acetone
monooxygenase (ACMO) from the actinobacterium Gordonia sp.
TY-5 and methyl ketone monooxygenase (MEKMO) from the pro-
teobacterium Pseudomonas veronii, strain MEK700. The protein of
P. patens forms a cluster with two  other enzymes of actinobacterial
origin: PAMO and steroid monooxygenase (STMO) from Rhodococ-
cus rhodochrous. The observed homologies were considered for the
discussion below.
The intron-less coding gene for the putative BVMO from C. mero-
lae is present in chromosome 12 of the organism. The primary
structure of the translated protein, which is annotated in GenBank
as a steroid monooxygenase (BAM80902.1), shares 43% identity
with the sequence of PAMO, 37% with cyclohexanone monooxyge-
nase (CHMO) from Acinetobacter NCIMB 9871 and 50% with CHMO
from Rhodococcus Phi1.
The 536 amino acids long putative enzyme from P. patens (pre-
dicted protein XP 001758613.1 in the NCBI data bank) is also coded
by a continuous open reading frame of the nuclear genome; it
shows 54% sequence identity with PAMO and 44% with CHMO from
Acinetobacter NCIMB 9871. One of the two ﬁngerprint motifs for
type I BVMO is, however, not strictly conserved but differs in one
amino acid: FxGxxxYxxxWP instead of FxGxxxHxxxWP (Fig. 1).
This is noteworthy, since it is known that the central histidine of
this consensus sequence (His173 in PAMO) is involved in cataly-
sis and FAD binding [26]. For this reason we planned to study the
wild-type form of the putative ﬂavoenzyme in comparison with
a mutant form in which the consensus motif would be artiﬁcially
repaired.
The identiﬁed coding sequences together with the variant
obtained by site-directed mutagenesis were cloned into the
pET28a(+) expression vector, permitting their translation in the
form of fusion proteins with carboxy-terminal hexahistidine tags.
The recombinant enzymes were designated Cm-BVMO (from C.
merolae), and Pp-BVMO (from P. patens)  and Pp-Y160H-BVMO.
Overexpression tests were then performed in E. coli BL21(DE3)
strain and parameters such as temperature and IPTG concentra-
tion were optimized. In all cases the proteins were expressed at
very high level and were mostly present in the cell debris after cell
homogenization, indicating insolubility. To overcome this problem,
different known strategies were unsuccessfully tried: expression
at low temperature in a bacterial strain containing cold-adapted
chaperones (E.coli ARCTIC Express®) or fusion with partners favor-
ing solubility (bacterial MBP  and yeast SUMO) (data not shown).
Only upon addition to the culture medium of an excess of riboﬂavin,
the precursor of FAD, bright yellow colored recombinant enzymes
could be recovered in the soluble fraction of the homogenate. This
result underlines the requirement of the ﬂavin cofactor for correct
folding of BVMOs.
The proteins were puriﬁed to homogeneity by IMAC chromatog-
raphy (Fig. 3); the evaluated yields were 45 mg for Cm-BVMO,
9.5 mg  for Pp-BVMO and 10 mg  for Pp-Y160H-BVMO per liter
148 E. Beneventi et al. / Journal of Molecular Catalysis B: Enzymatic 98 (2013) 145– 154
Fig. 1. CLUSTALW Multiple sequence alignment of new BVMOs, PAMO and CHMO. CLUSTALW Multiple sequence alignment of phenylacetone monooxygenase from Thermob-
i 1 (CHM





















rﬁda  fusca (PAMO), cyclohexanone monooxygenase from Acinetobacter NCIMB 987
erolae (Cm-BVMO). The two Rossmann fold domains (GxGxx(G/A), ATG) and th
ighlighted. Number of omitted terminal residues is in brackets.
f bacterial culture. They were tested in reactions with rac-
icyclo[3.2.0]hept-2-en-6-one as substrate, a benchmark molecule
or Baeyer–Villiger monooxygenase activity. Conversion of the
ubstrate, as observed by consumption of NADPH, conﬁrmed the
ature of the newly discovered enzymes and prompted their fur-
her characterization.
.2. pH and temperature proﬁles
All recombinant type I BVMOs showed a bell-shaped pH pro-
le in reactions with rac-bicyclo[3.2.0]hept-2-en-6-one. Maximum
ctivity was measured at pH 8.5 for Cm-BVMO; at pH 8.0 for
p-BVMO and Pp-Y160H-BVMO. The latter optimum pH value cor-
esponds to that found for PAMO, whereas pH 7.5 and 9 are the
alues respectively reported for HAPMO (4-hydroxyacetophenone
onooxygenase) and CHMO (cyclohexanone 1,2-monooxygenase;
27]).
Temperature optima were measured between 17 ◦C and 70 ◦C.
nzymatic activity of Cm-BVMO increased with temperature up to
0 ◦C: at this temperature initial enzymatic activity was ﬁve-fold
igher compared to that measured at 30 ◦C. The enzyme from C.
erolae also demonstrated considerable thermostability, since its
ctivity was fully retained in incubation for 1.5 h in the temperature
ange between 20 ◦C and 42 ◦C. Higher incubation temperaturesO) and novel BVMOs from Physcomitrella patens (Pp-BVMO) and Cyanidioschyzon
BVMO ﬁngerprint motifs (FxGxxxHxxxW [20] and GGxWxxxxYPGxxxD [24]) are
led to inactivation of the enzyme. Considering that the red alga
typically grows at 45 ◦C, this result was not unexpected. Unfol-
ding experiments using the ThermoFAD method revealed that the
melting temperature (Tm) of Cm-BVMO was  56 (±0.5) ◦C, which
is considerably higher than that of most known BVMOs. To our
knowledge, the only other thermostable type I BVMO found so
far is PAMO, i.e. the enzyme discovered by Fraaije et al. [22] in
Thermobiﬁda fusca, that exhibits an activity half-life of 24 h at 52 ◦C
and a Tm of 61 ◦C.
Optimal temperatures for Pp-BVMO and Pp-Y160H-BVMO were
probed between 17 ◦C and 40 ◦C: they resulted around 25 ◦C and
30 ◦C respectively for Pp-BVMO and Pp-Y160H-BVMO. Concern-
ing stability, after 1.5 h incubation between 17 ◦C and 25 ◦C both
enzymes retained their activity. Tm of Pp-BVMO and mutant Pp-
Y160H-BVMO were 44.0 (±0.5) ◦C and 43.5 (±0.5) ◦C respectively.
Apparently, the restored histidine residue in the ﬁngerprint motif of
the mutant did not signiﬁcantly inﬂuence the melting temperature
of the enzyme.
3.3. Substrate scopeTo explore the biocatalytic potential of the two  eukaryotic
BVMOs, a broad range of potential substrates was  used in a so-called
phosphate assay [24]. In this indirect assay the Baeyer–Villiger


























Fig. 2. Phylogenetic analysis of Cm-BVMO, Pp-BVMO and selected BVMOs. MUSCLE multialignment of 26 type I BVMOs (selected as described in Section 3.1) was  used as
input  into MEGA program version 5.0 [40] in order to generate a phylogenetic tree using the neighbor-joining method [41] with an associated bootstrap analysis, based
on  1000 replications. The tree was visualized using Dendroscope 3 [42]. Abbreviations and GenBank accession numbers of protein sequences: CHMO Acinetobacter, CHMO
Acinetobacter sp. NCIMB 9871 (BAA86293); CHMO1 Brevibacterium, CHMO 1 Brevibacterium sp. HCU (AAG01289); CHMO2 Brevibacterium, CHMO 2 Brevibacterium sp. HCU
(AAG01290); CHMO1 Rhodococcus, CHMO Rhodococcus sp. Phi1 (AAN37494); CHMO2 Rhodococcus, CHMO Rhodococcus sp. Phi2 (AAN37491); CHMO Arthrobacter, CHMO
Arthrobacter sp. BP2 (AAN37479); CHMO Brachymonas, CHMO Brachymonas petroleovorans (AAR99068); CHMO Xanthobacter, CHMO Xanthobacter sp. ZL5 (CAD10801);
CPMO, cyclopentanone monooxygenase Comamonas sp. NCIMB 9872 (BAC22652); PAMO, phenylacetone monooxygenase Thermobiﬁda fusca (PDB: 1W4X A); HAPMO P.
ﬂuorescens, 4-hydroxyacetophenone monooxygenase Pseudomonas ﬂuorescens (AAK54073); STMO, steroid monooxygenase Rhodococcus rhodochrous (BAA24454); CDMO,
cyclododecanone monooxygenase Rhodococcus rubber (AAL14233); EtaA, EtaA Mycobacterium tuberculosis H37Rv (CAB06212); CPDMO, cyclopentadecanone monooxygenase
Pseudomonas sp. HI-70 (BAE93346); ACMO, acetone monooxygenase Gordania sp. strain TY-5 (BAF43791); MEKMO, methylethylketone monooxygenases Pseudomonas veronii
MEK700  (ABI15711); OTEMO, (3)-4,5,5-trimethylcyclopentenylacetyl-coenzyme A monooxygenase Pseudomonas putida ATCC 17453 (H3JQW0); CAMO, cycloalkanone
monooxygenase Cylindrocarpon radicicola ATCC 11011 (AET80001); BVMO AF1, BVMO Aspergillus fumigatus Af293 (NCBI: XM 742067); PtlE, BVMO Streptomyces avermitilis











putida,  HAPMO Pseudomonas putida (ACJ37423).
xidation is coupled with a regeneration reaction catalyzed by
hosphite dehydrogenase (PTDH). PTDH is able to generate one
olecule of phosphate from a molecule of phosphite in water,
ith simultaneous regeneration of one molecule of NADPH. The
ormed phosphate can be quantiﬁed by using a chromogenic reac-
ion that allows spectrophotometric detection of the degree of
onversion.
ig. 3. Expression and puriﬁcation of His-tagged Pp- and Cm-BVMOs. 12% SDS-PAGE ana
ractions from progressive puriﬁcation fractions were loaded: protein standard marker (
ellet  fraction (p) and soluble protein fraction (sur), ﬂow trough (Ft) and elution fractionsBy using this assay, a collection of 46 potential substrates for
BVMOs was tested. They were chosen among different classes of
molecule, e.g. linear and cyclic aliphatic ketones, aryl and aromatic
ketones, steroids, aromatic amines, and aromatic sulphides. The
substrate scope obtained for each enzyme is summarized in Table 1.
In general, all the three BVMOs seem to have a broad sub-
strate scope. As expected, they exhibited signiﬁcant activity against
lysis of cell extracts from E. coli cells expressing Pp-BVMO (A) and Cm- BVMO (B).
M), total cell extracts from non induced cells (NI) or over night induced cells (ON),
 (E).
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Table 1
Substrate scope.
Substrate Cm Pp PpY160H
Acetone +
Methylketone + +
Methyl vinyl ketone + + +
2-Octanone ++ ++ +++
3-Octanone + ++ +
4-Octanone +
2-Dodecanone +++ ++ +++
3-Methyl-2,4-pentanedione + +
Cyclobutanone + + +



























3-Phenylpentane-2,4-dione ++ ++ +++
Phenylacetone +++ ++ +++







Observed activities for Cm-BVMO, Pp-BVMO and Pp-Y160H-BVMO, measured by
phosphate formation. Activities are indicated as +, ++ or +++ and reﬂect a 1.2-, 2- or 5-
fold increase in phosphate formation, respectively, when compared with uncoupling


















blocks for the chemical synthesis of prostaglandins; their pro-
duction has been therefore studied in conversion experiments byac-bicyclo[3.2.0]hept-2-en-6-one, the above-mentioned typical
ubstrate for type I BVMOs. Good activities were also observed
or linear ketones, in particular long-chain alkanones. Phenylace-
one and some derivatives also seemed to be easily accepted as
ubstrates, as well as some cyclic ketones like cyclopentanone. It
s worth noting that, by directly comparing results collected for
p-BVMO and for Pp-Y160H-BVMO, the mutant displays higher
ctivity and larger substrate proﬁle. This result is in agreement
ith the fundamental role reported for the central histidine of the
VMO consensus motif in catalysis and FAD binding. Indeed, in site-
irected mutants of 4-hydroxyacetophenone monooxygenase from
seudomonas ﬂuorescens (His296Ala; [19]) and of cyclohexanone
onooxygenase from Acinetobacter NCIB 9871 (His163Gln; [28]),
t was shown that substitution of this residue drastically reduces
r nearly abolishes activity.
Other potential substrates tested with the new BVMOs, such as
cetone, indanone, phenindione, cyclopentadecanone, benzoin and
teroids, were found to be poor or not accepted substrates.lysis B: Enzymatic 98 (2013) 145– 154
3.4. Steady-state kinetics
Steady-state kinetic parameters of the three recombinant
enzymes were determined in 50 mM Tris/HCl using the optimal
conditions deﬁned for each enzyme, that are pH 8.0, at 25 ◦C for Pp-
and Pp-H160Y BVMOs and pH 8.5, at 35 ◦C for Cm-BVMO. All the
three enzymes showed a typical Michaelis–Menten behavior. The
kinetic parameters kcat and KM were calculated for a set of iden-
tiﬁed substrates besides rac-bicyclo[3.2.0]hept-2-en-6-one, used
in the preliminary assay. Selected substrates were linear aliphatic
ketones, cyclic aliphatic ketones and aromatic ketones. In particu-
lar, for the linear ketone containing eight carbon atoms, the position
of the keto group in the molecule was investigated. Tables 2 and 3
summarize the results obtained for Cm-BVMO, and Pp- and Pp-
Y160H BVMOs, respectively.
Cm-BVMO exhibited the best catalytic efﬁciency against 2-
dodecanone (kcat/KM 90.8 s−1 mM−1). Octanones also appeared to
be good substrates. In particular, by comparing KM and kcat/KM val-
ues reported in Table 2, the position of the keto group at C3 seemed
to be preferred. By limiting the observation to the positions of the
carbonyl function in octanone, it can be noticed that the Michaelis
constant is the main parameter inﬂuencing the catalytic efﬁciency,
since the kcat values were similar for all investigated positions of
the keto groups.
Also for Pp- and Pp-Y160H BVMOs, linear ketones seemed to be
very well accepted substrates (Table 3). 2-dodecanone was  the one
for which the enzymes display the highest catalytic efﬁciency. Dif-
ferently from the enzyme from C. merolae, the one from P. patens
preferred the keto group at position 2 of octanone. 4-octanone was
not a good substrate for either wt or mutant enzymes, as already
observed in the previous substrate-screening assay (Table 1). kcat
values, for all the four linear C8-ketones tested, were approximately
in the same range of those measured for the algal enzyme. As
discussed above in relation to the activity and substrate proﬁle,
restoration of the consensus histidine makes the mutant variant
of Pp-BVMO more competent for catalysis and faster than the wt
form, showing higher turnover number.
All the recombinant enzymes were able to oxidize some substi-
tuted aryl ketones, like phenylacetone and 4-(4-hydroxyphenyl)-2-
butanone. The latter compound was a good substrate, particularly
for Pp- and Pp-Y160H BVMOs. Due to the limited solubility,
other substrates such as 4-dimethylaminobenzaldehyde and 3-
acetylindole could not be investigated by kinetic analysis. Finally,
the afﬁnity for coenzyme NADPH was  found to be very high, as a
KM values <5 M were determined.
3.5. Conversions
Biotransformations using puriﬁed enzymes and different types
of substrates were investigated using GC and GC-MS analysis in
order to detect both substrates and products. PTDH and phosphite
were added for NADPH regeneration.
As already mentioned, rac-bicyclo[3.2.0]hept-2-en-6-one is a
standard probe for testing the biocatalytic potential of type I
BVMOs. This conversion is a good example of regiodivergent
parallel kinetic resolution (PKR) because the racemic substrate
leads to two  regioisomeric compounds (−)-(1S,5R) 2 and (−)-
(1R,5S) 3 (Fig. 4A). One compound originates from the favored
Baeyer–Villiger-type oxygen insertion between the more substi-
tuted carbon atom and the carbonyl group in a fast reaction; the
second lactone is more slowly produced in the chemically disfa-
vored regiochemistry. The two chiral lactones are relevant buildingusing different strains, i.e. different BVMOs. Some examples of
such studies are those regarding CHMO from Acinetobacter [29],
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Table  2
Steady-state kinetic analysis of Cm-BVMO.
Substrate KM [mM] kcat [s−1] kcat/KM [s−1 mM]
2-Dodecanone
O
0.004 ± 0.001 0.383 ± 0.018 90.8
Octanal O 0.010 ± 0.008 0.252 ± 0.043 25.3
2-Octanone
O
0.011 ± 0.006 0.250 ± 0.031 22.7
3-Octanone
O
0.0030 ± 0.0005 0.210 ± 0.006 70
4-Octanone
O
0.0040 ± 0.0009 0.202 ± 0.006 50.5
4-(4-Hydroxyphenyl)-2-butanone HO O 0.0070 ± 0.0007 0.079 ± 0.002 11.2
Bicyclo[3.2.0]hept-2-en-6-one
O












yclopentanone monooxygenase (CPMO) from Pseudomonas sp.
CIMB 9872 [30] and 4-hydroxyacetophenone monooxygenase
HAPMO) from Pseudomonas ﬂuorescens ACB [5].
In our experiments, biooxidation of the rac-bicyclo[3.2.0]hept-
-en-6-one racemic substrate led to the production of all four
ossible lactone products by the three BVMOs, and the observed
able 3
teady-state kinetic analysis of Pp- and Pp-Y160H BVMOs.
Substrate Pp 
KM [mM] kcat [s−1]
2-Dodecanone
O
0.00040 ± 0.00008 0.096 ±
Octanal O 0.019 ± 0.009 0.061 ±
2-Octanone
O
0.0030 ± 0.0008 0.060 ±
3-Octanone
O










0.0060 ± 0.0001 0.058 ±
Phenylacetone O 0.038 ± 0.016 0.077 ±0.097 ± 0.071 0.032 ± 0.006 0.3
ee values suggested poor enantioselectivity toward this racemic
substrate. “Normal” lactones for both fast and slow reactions were
mainly produced.
The behavior of Cm-BVMO revealed (as shown for HAPMO [5]),
a signiﬁcant preference for the (+)-(1R,5S) 1 enantiomer. Regio-
selectivity was  scarce for both the preferred and non-preferred
PpY160H
 kcat/KM [s−1 mM]  KM [mM]  kcat [s−1] kcat/KM [s−1 mM]
 0.002 240 0.0020 ± 0.0004 0.252 ± 0.011 126
 0.004 3.2 0.0030 ± 0.0008 0.125 ± 0.006 41.7
 0.002 20 0.0030 ± 0.0006 0.204 ± 0.007 68
 0.008 7.5 0.016 ± 0.007 0.123 ± 0.011 7.6
– – – –
 0.004 34 0.0030 ± 0.0007 0.152 ± 0.006 50.7
 0.0001 9.7 0.016 ± 0.002 0.120 ± 0.005 7.5
 0.009 2 0.032 ± 0.009 0.146 ± 0.011 4.6
152 E. Beneventi et al. / Journal of Molecular Catalysis B: Enzymatic 98 (2013) 145– 154
Table 4
Regiodivergent biooxidation by Cm-, Pp- and Pp-Y160H BVMOs.
Substrate Cm Pp PpY160H
% Conv ratio % ee % Conv ratio % ee % Conv ratio % ee
OH
H


















































Slow reaction 100 88:12 66 
 Conv, percentage yield of conversion; ratio, ratio between produced normal and a
ubstrate enantiomers, that respectively produced 73% (−)-(1S,5R)
 versus 27% (+)-(1S,5R)  3, and 88% (+)-(1R,5S) 2 and 12% (+)-(1R,5S)
, enantiomers. All four possible lactone products, in different
mounts, were therefore ﬁnally obtained (Fig. 4B). The ee values
f the product mixture resulting from complete conversion were
2% for the “normal” (+)-(1R,5S) 2 and 37% for the “abnormal”
+)-(1S,5R) 3. (Table 4). After 5 h, the racemic substrate was  fully
onverted.
Pp- and Pp-Y160H BVMOs approximately showed the same
ehavior (Fig. 4C and D) (Table 4). The favored substrate was the
+)-(1R,5S) 1 enantiomer for both enzymes; they respectively pro-
uced 76% and 72% of the expected (−)-(1S,5R) 2 versus 24% and
8% of the (+)-(1S,5R)  3. The mutant enzyme, compared to the
ild-type one, exhibited much higher regioselectivity in the slow
onversion of the (−)-(1S,5R) 1 substrate, yielding 95% of the
xpected lactone and 5% of the unexpected one. In such slow reac-
ion, the WT  enzyme yielded only 62% of the expected and 4%
nexpected lactone and the conversion was not complete (66%)
fter 16 h. As for the case of the conversion by Cm-BVMO, ee values
or the “normal” and “abnormal” enantiomeric products were too
ow to be considered for a direct biocatalytic application of the new
nzymes.
Conversions by Cm-, Pp- and Pp-Y160H BVMOs were also eval-
ated with other compounds, chosen among those previously
dentiﬁed as substrates. As shown in Table 5, conversion of these
etones resulted in the formation of the expected ester prod-
ct, obeying the stereo-chemical rule of Baeyer–Villiger reactions
here the migrating group is the most substituted one. In partic-
lar, 2-octanone, 3-octanone and 4-octanone were fully converted
y Cm-BVMO. The mutated BVMO from Physcomitrella performed
ull conversion of 2-octanone and 3-octanone and poor transfor-
ation of 4-octanone, whereas the unmodiﬁed enzyme was able
o oxidize in good amount only the ﬁrst two linear ketones. Finally
henylacetone was fully converted by all the three enzymes. The
ecombinant enzymes gave poor or almost no conversion of the
yclic ketones cyclohexanone and cyclopentanone; only Cm-BVMO
as able to transform the former molecule.
. Discussion
BVMOs are currently in the spotlight of industrial biocatalysis
or their capability to perform challenging steps in organic chemical
rocesses, such as oxidations of ketones to esters (Baeyer–Villiger
xidations), but also sulfoxidations and other oxidative reac-
ions. Up to 2012, all reported type I BVMOs originated from 100 95:5
al lactones; % ee,  percentage enantiomeric excess values.
microbial organisms, particularly actinobacteria and ﬁlamentous
fungi. Only two BVMOs of eukaryotic origin have been identiﬁed
and expressed in recombinant form very recently: the BVMOs from
the ascomycetes Cylindrocarpon radicicola ATCC 11011 [20] and
Aspergillus fumigatus Af293 [21]. We  have identiﬁed and selected
two new putative BVMOs from the photosynthetic eukaryotes
Cyanidioschizon merolae and Physcomitrella patens.
The two organisms can be certainly considered very uncom-
mon  sources for BVMOs, being eukaryotic and photosynthetic. The
primitive red alga C. merolae 10D is a unicellular organism living
in acidic environments (like hot springs), even at pH < 2 and tem-
perature of 45 ◦C. It is one of the photosynthetic eukaryotes with
the most simple cell architecture: its cell does not present a rigid
cell wall and contains a single nucleus, a single mitochondrion and
a single chloroplast. This clearly offers advantages for studies on
these organelles [29,30]. The moss P. patens is classiﬁed as a no
vascular plant, since it differs from higher plants in not having inter-
nal vessels [31], and stands in an important phylogenetic position
for studying the evolutionary transition from the aquatic environ-
ment of algae to the terrestrial one of higher plants. Noticeably,
both organisms undergo homologous recombination with a fre-
quency that allows easy targeting of genes for replacement and
elimination [32,33]. This allows handy studying of gene func-
tion and helps in predicting the physiological role of genes in
higher organisms. P. patens and C. merolae are therefore considered
model systems for studying origin and fundamental mechanisms
of eukaryotic cells and plant evolution.
We succeeded in producing the identiﬁed putative BVMOs
in recombinant form, together with a mutant variant of the
protein from Physcomitrella completely restored in the consen-
sus sequence ﬁrstly described. The second BVMO-typifying motif
([A/G]GxWxxxx[F/Y]P[G/M]xxxD), recognized and annotated after
the beginning of our work [24], is fully conserved in both proteins.
The biocatalytic characterization of the recombinant products
could demonstrate their BVMO activity on a broad range of sub-
strates as linear and cyclic aliphatic ketones, aryl and aromatic
ketones (Table 1). Among linear ketones (C8 and C12), proven to
be the best substrates, 2-dodecanone was the preferred one.
In an overview of the data from the kinetic analysis, the
three enzymes displayed different rates of catalysis, depending
on the substrate examined (Tables 2 and 3), but in all cases mea-
sured kcat values were not higher than 0.4 s−1. Since most natural
monooxygenase enzymes display kcat values in the range of
1–100 s−1 when tested on ketones among those selected for our
analysis [34], we  conclude that the new BVMOs (at least as such)
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Fig. 4. Biooxidation of racemic bicyclo[3.2.0]hept-2-en-6-one. Possible structures of bicyclo[3.2.0]hept-2-en-6-one isomers and lactones formed by type I BVMO activity (A).
Time  course of Cm-  (B), Pp- (C) and Pp-Y160H- (D) BVMOs catalyzed oxidation of racemic bicyclo[3.2.0]hept-2-en-6-one to 2-oxabicyclo[3.3.0]oct-6-en-3-one (+)-(1S,5R)
2/(−)-(1R,5S) 2 and 3-oxabicyclo[3.3.0]oct-6-en-2-one (−)-(1S,5R) 3/(+)-(1R,5S) 3.
Table 5
Conversion of some identiﬁed substrates and corresponding products.
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eem rather inefﬁcient bio-catalysts. This is also true in terms
f enantioselectivity, which was shown to be very poor when
robed on the typical substrate racemic bicyclo[3.2.0]hept-2-en-
-one (Table 4), transformed in the four possible lactone.
Nevertheless, some results deserve to be highlighted. As known
rom the literature, representative BVMOs can be clustered in well-
eﬁned groups with different substrate proﬁle. The phylogenetic
nalysis that we  performed (Fig. 2) places the new BVMOs in two
istinct positions. The protein from P. patens is localized in the clade
eﬁned by PAMO and STMO, which transform aromatic (but also
inear) ketones; the one from C. merolae is clustered together with
EKMO  and ACMO, enzymes known for converting linear ketones
35,36]. This grouping is in agreement with the substrate scope
btained for the recombinant enzymes even though, because of
heir eukaryotic origin, a different biocatalytic behavior could be
xpected.
The second noteworthy result concerns the central histidine of
he motif FxGxxxHxxxWP: this residue, although dispensable for
atalysis and not always conserved (see [21] and [24]), has been
roposed to be involved in conformational changes occurring along
ith catalysis [26]. Its fundamental role has been already shown
19,28]. By comparing activities of wild type and mutant Pp-BVMOs,
e further conﬁrm here that this histidine is certainly important
or enzymatic performance.
Finally, we could show that the enzyme from Cyanidioschizon
isplays a relatively high thermostability by having an apparent
elting temperature of 56 ◦C. This compares favorably with other
ell-studied BVMOs: CHMO has a Tm of 39 ◦C (near to the value
hat we measured for Pp-BVMO, i.e. 44 ◦C), while PAMO has a Tm
nly ﬁve degrees higher than that measured for Cm-BVMO [37]. If
rotein engineering will be considered to boost the enzyme activ-
ties in view of a possible re-consideration of their utility, the
rimary sequence of Cm-BVMO could be a favorable starting point.
In the same perspective, a better characterization of the reper-
oire of accepted molecules could also be useful. The displayed
ery low catalytic efﬁciency suggests that during evolution the
wo new BVMOs had been subjected to a weak selective pressure.
ence, according to the current view, a potential role as secondary
etabolism enzymes can be envisaged [38,39]. Their substrate
references point toward linear alkanones, structurally similar to
ide chains of chlorophylls and pheophytins, and to their possible
nvolvement in modiﬁcations of photosynthetic pigments. Work is
n progress to produce knockout mutants in both the alga and the
oss, by exploiting their endogenous homologous recombination.
omparison of null mutants with wild-type strains would help in
ncovering the natural substrates of Cm-  and Pp-BVMOs in their
riginal biological context.
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